Chugai to File Flurry of Applications in 2017 for New Drugs and Indications Including Emicizumab

February 3, 2017
Chugai Pharmaceutical plans to submit seven applications for new drugs and indications in 2017. “This year (2017) will see a flurry of application filings,” said President and COO Tatsuro Kosaka at an earnings conference on February 1. These include two...read more